EDWARDS LIFESCIENCES CORP (EW)       80.04  +0.95 (+1.2%)

80.04  +0.95 (+1.2%)

US28176E1082 - Common Stock - After market: 80.05 +0.01 (+0.01%)

EDWARDS LIFESCIENCES CORP80.04

NYSE:EW (2/7/2023, 7:04:00 PM)+0.95 (+1.2%)

After market: 80.05 +0.01 (+0.01%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 01-31 2023-01-31/amc Earnings (Next) 04-24 2023-04-24/amc
Ins Owners 0.16% Inst Owners 80.44%
Market Cap 49.49B Shares 618.26M
PE 32.8 Fwd PE 30.89
Dividend Yield N/A Analysts 75.29
IPO 03-27 2000-03-27

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

EW Daily chart

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,700 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. The company also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.

Company Info

EDWARDS LIFESCIENCES CORP

One Edwards Way

Irvine CALIFORNIA 92614

P: 19492502500.0

CEO: Michael A. Mussallem

Employees: 15700

Website: https://www.edwards.com

EW News

News Image2 days ago - ChartmillWhich S&P500 stocks are moving on Monday?

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.

News Image2 days ago - ChartmillThese S&P500 stocks are gapping in today's session

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

News Image6 days ago - Market News VideoInteresting EW Put And Call Options For March 24thNews Image7 days ago - The Motley Fool2 Top Dividend Growth Stocks to Buy in February

They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.

News Image7 days ago - Market News VideoJohnson Controls International Takes Over #160 Spot From Edwards LifesciencesNews Image7 days ago - Seeking AlphaEdwards Lifesciences Non-GAAP EPS of $0.64 beats by $0.03, revenue of $1.35B beats by $20M (NYSE:EW)

Edwards Lifesciences press release (EW): Q4 Non-GAAP EPS of $0.64 beats by $0.03.Revenue of $1.35B (+1.5% Y/Y) beats by $20M.Shares +2.3%.Q4 TAVR sales were flat; constant...

EW Twits

Here you can normally see the latest stock twits on EW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example